National Storage Mechanism | Additional information 
RNS Number : 0318Z
Baronsmead Venture Trust PLC
11 September 2025
11 September 2025
BARONSMEAD VENTURE TRUST PLC
("THE COMPANY")
|
|
|
|
| 1. |
Details of PDMR / person closely associated with them ("PCA") |
|
|
| a) |
Name |
Michael Probin |
|
| 2. |
Reason for the notification |
|
|
| b) |
Position / status |
Non-Executive Director |
|
| c) |
Initial notification / amendment |
Initial Notification |
|
| 3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
| a) |
Name |
Baronsmead Venture Trust plc |
|
| b) |
LEI |
213800VQ1PQHOJXDDQ88 |
|
| 4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
| a) |
Description of the financial instrument
Identification Code |
Ordinary Shares of £0.10 each
ISIN: GB0002631934 |
|
| b) |
Nature of the transaction |
Acquisition of shares through participation in the Dividend Reinvestment Plan |
|
| c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
| £0.4836 |
4,681 |
|
|
| d) |
Aggregated information
Aggregated volume
Price |
N/A - single transaction |
|
| e) |
Date of the transaction |
09/09/2025 |
|
| f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
For further information please contact:
Baronsmead VCT Investor Relations
020 7382 0999
[email protected]
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFIRADILLIE